Zyngenia
9800 Medical Center Drive
Suite C-120
Rockville
Maryland
20850
United States
10 articles about Zyngenia
-
Zyngenia Publishes New Data Demonstrating Preclinical Efficacy of its Multi-Specific Antibody Therapeutics in Treating Cancer
3/1/2013
-
Zyngenia Expands Its Board of Directors With Leading Life Sciences Business Executives Christian Itin and Jason Rhodes
10/11/2012
-
Zyngenia Appoints Frank Hsu, M.D., as Chief Medical Officer
5/31/2012
-
Zyngenia Recruits David Parkinson, M.D., as Board Member, Clinical Advisory Board Head, and Interim Chief Medical Officer
4/25/2012
-
Zyngenia Promotes Chief Scientific Officer and Hires Chief Business Officer
12/12/2011
-
After Decades in the Industry, Ex MedImmune and Bristol-Myers Squibb Company Biotech Veteran Kiener Leads Gaithersburg's Zyngenia
7/15/2011
-
Zyngenia Raises $15 Million in Series A Extension Financing
9/8/2010
-
Antitope Announces EpiScreen Collaboration with Zyngenia
6/10/2010
-
Biotech Startup Zyngenia Lands $1.5M In Public Funds
2/16/2010
-
Zyngenia (JOBS) Raises $10 Million in Series A Funding
11/5/2009